Trial Profile
Change of Renal Function and Bone Mineral Density Marker in Chronic Hepatitis B Patients Switching From TDF to TAF vs. Maintaining TDF
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 22 Dec 2022
Price :
$35
*
At a glance
- Drugs Tenofovir alafenamide (Primary) ; Tenofovir disoproxil fumarate
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms SWITAF
- 19 Dec 2022 Planned End Date changed from 1 Oct 2023 to 1 Oct 2024.
- 19 Dec 2022 Planned primary completion date changed from 1 Oct 2022 to 1 Oct 2023.
- 05 Jun 2018 Results (n=75) presented at the Digestive Disease Week 2018.